Education
About Us
Working with TipRanks
Follow Us
Shanghai Junshi Biosciences Co., Ltd. Class H (HK:1877)
:1877
RESEARCH TOOLSreports
Comparison Results
Shanghai Junshi Biosciences Co., Ltd. Class H
HK$25.10
HK$38.89B
―
94.88%
0 Buy
1 Hold
0 Sell
Hold
Shanghai Henlius Biotech, Inc. Class H
HK$63.50
HK$32.42B
38.80
182.85%
1 Buy
0 Hold
0 Sell
Moderate Buy
Ascentage Pharma Group International
HK$76.80
HK$25.55B
―
160.78%
0 Buy
0 Hold
0 Sell
Hold
Performance Comparison
HK:1877
Shanghai Junshi Biosciences Co., Ltd. Class H
25.10
12.42
97.95%
DE:1ZLB
Zai Lab Ltd
3.08
1.45
88.96%
HK:9966
Alphamab Oncology
8.30
6.07
272.20%
HK:9995
RemeGen Co. Ltd. Class H
68.95
53.45
344.84%
HK:2696
Shanghai Henlius Biotech, Inc. Class H
63.50
41.05
182.85%
HK:6855
Ascentage Pharma Group International
76.80
48.50
171.38%